Greater Cannabis Company (GCAN) Other Non Operating Income (2016 - 2025)
Greater Cannabis Company's (GCAN) quarterly Other Non Operating Income came in at -$57920.0 in Q1 2025, down 5792100.0% quarter-over-quarter from $1.0 in Q4 2021.
Greater Cannabis Company (GCAN) Other Non Operating Income (2016 - 2025) Analysis & Trends
Greater Cannabis Company's Other Non Operating Income history runs 7 years deep, the most recent figure standing at -$57920.0 for Q1 2025.
- On a quarterly basis, Other Non Operating Income changed N/A year-over-year to -$57920.0 in Q1 2025; TTM through Mar 2025 was $290199.0, a N/A change from a year earlier, with the FY2025 full-year figure at $80776.0, changed N/A from the prior year.
- Other Non Operating Income eased to -$57920.0 in Q1 2025 per GCAN's latest filing, from $1.0 in the prior quarter.
- Across five years, Other Non Operating Income topped out at $400834.0 in Q2 2021 and bottomed at -$57920.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Greater Cannabis Company | 292,929.85 | 292,929.85 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | -57,920.00 |
| Dec 31, 2021 | 1.00 |
| Sep 30, 2021 | -52,716.00 |
| Jun 30, 2021 | 400,834.00 |
| Mar 31, 2021 | 6,536.00 |
| Dec 31, 2020 | 2.05 Mn |
| Sep 30, 2020 | 213,751.00 |
| Jun 30, 2020 | -132,838.00 |
| Mar 31, 2020 | -228,949.00 |
| Dec 31, 2019 | -498,532.00 |
| Sep 30, 2019 | 24,035.00 |
| Jun 30, 2019 | 82,065.00 |
| Mar 31, 2019 | 88,451.00 |
| Dec 31, 2018 | 202,357.00 |
| Sep 30, 2018 | -212,165.00 |
| Jun 30, 2018 | 31,847.00 |
| Mar 31, 2018 | 5,903.00 |
| Dec 31, 2017 | 9,902.00 |
| Sep 30, 2017 | 41,151.00 |
| Jun 30, 2017 | 132,850.00 |